Prestige Consumer Healthcare, Inc. (PBH)

49.06 +0.31 (+0.64%) USD  |  NYSE  |  Oct 30, 16:00
49.07 +0.01 (+0.02%) Pre-Market: 20:00
More

Prestige Consumer Healthcare Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for PBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2008. Start Trial.
Date Value
March 31, 2008 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Supernus Pharmaceuticals, Inc. Upgrade
Phibro Animal Health Corp. Upgrade
Structure Therapeutics, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade